Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability
eLife · 24.05.2024 · 13
DOI: 10.7554/elife.95652.3 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, online erschienen am 24.05.2024. Verfasst von Keene L Abbott und 20 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Foundation, National Cancer Institute, National Institutes of Health.
Abstract (Originalsprache)
The tumor microenvironment is a determinant of cancer progression and therapeutic efficacy, with nutrient availability playing an important role. Although it is established that the local abundance of specific nutrients defines the metabolic parameters for tumor growth, the factors guiding nutrient availability in tumor compared to normal tissue and blood remain poorly understood. To define these factors in renal cell carcinoma (RCC), we performed quantitative metabolomic and comprehensive lipidomic analyses of tumor interstitial fluid (TIF), adjacent normal kidney interstitial fluid (KIF), and plasma samples collected from patients. TIF nutrient composition closely resembles KIF, suggesting that tissue-specific factors unrelated to the presence of cancer exert a stronger influence on nutrient levels than tumor-driven alterations. Notably, select metabolite changes consistent with known features of RCC metabolism are found in RCC TIF, while glucose levels in TIF are not depleted to levels that are lower than those found in KIF. These findings inform tissue nutrient dynamics in RCC, highlighting a dominant role of non-cancer-driven tissue factors in shaping nutrient availability in these tumors.
Förderung
- National Science Foundation
- National Cancer Institute
- National Institutes of Health
- Howard Hughes Medical Institute
- American Association for Cancer Research
- Ludwig Cancer Center at Harvard
- Nile Albright Research Foundation
- National Foundation for Cancer Research
Zitieren
APA
Abbott, K. L., Ali, A., Reinfeld, B. I., Deik, A., Subudhi, S., Landis, M. D., Hongo, R. A., Young, K. L., Kunchok, T., Nabel, C. S., Crowder, K. D., Kent, J. R., Madariaga, M. L. L., Jain, R. K., Beckermann, K. E., Lewis, C. A., Clish, C. B., Muir, A., Rathmell, W. K., …, & Heiden, M. G. V. (2024). Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability. eLife, 13. https://doi.org/10.7554/elife.95652.3
Vancouver
Abbott KL, Ali A, Reinfeld BI, Deik A, Subudhi S, Landis MD, et al. Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability. eLife. 2024;13. doi:10.7554/elife.95652.3
BibTeX
@article{Abbott2024,
author = {Abbott, Keene L and Ali, Ahmed and Reinfeld, Bradley I and Deik, Amy and Subudhi, Sonu and Landis, Madelyn D and Hongo, Rachel A and Young, Kirsten L and Kunchok, Tenzin and Nabel, Christopher S and Crowder, Kayla D and Kent, Johnathan R and Madariaga, Maria Lucia L and Jain, Rakesh K and Beckermann, Kathryn E and Lewis, Caroline A and Clish, Clary B and Muir, Alexander and Rathmell, W Kimryn and Rathmell, Jeffrey and Heiden, Matthew G Vander},
title = {Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability},
journal = {eLife},
year = {2024},
volume = {13},
doi = {10.7554/elife.95652.3}
}
EUVIMED